Viewing Study NCT02159820


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-04 @ 10:42 PM
Study NCT ID: NCT02159820
Status: UNKNOWN
Last Update Posted: 2014-06-10
First Post: 2014-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module